Research · Sep 3, 2026
[TRV] Travelers Thesis 2026: Bond & Specialty + Commercial P&C Pricing Cycle Drive Combined Ratio Recovery
Travelers Companies FY2025 net premiums written ~$48B (+10-12% YoY) with combined ratio recovered to 93.5% from FY2023 trough 97%. Adj. EPS ~$23.50 (vs $11.05 FY2023 trough = ~110% recovery in 2 years) reflects underwriting profitability recovery. Bond & Specialty Insurance franchise (~$4B revenue, ~80% combined ratio) structurally distinctive — Travelers #1 US surety bond underwriter at 25-30% market share with multi-decade specialized underwriting expertise + favorable economics. Business Insurance ($22B) benefits from continued commercial P&C pricing cycle. Personal Insurance ($17B) progressively recovering from FY2022-2023 cycle pressure. Book value per share compounding ~9% annually ($110 FY2022 → $143 FY2025). 22 consecutive year dividend aristocrat. FY2026 thesis: pricing cycle continuation + Personal Insurance combined ratio improving toward 92-94% + Bond & Specialty growth; key risks: pricing softening, catastrophe escalation, Personal Insurance recovery stalling.